We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CLS:JSEClicks Group Limited Analysis

Data as of 2026-06-04 - not real-time

ZAC 23,449.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Clicks Group Limited is trading well beneath its short‑ and long‑term moving averages, indicating a bearish technical backdrop, while the RSI signals an oversold condition that could set the stage for a short‑term bounce. Fundamentally, the stock trades at a price‑earnings multiple far lower than the industry average and the discounted cash‑flow model points to a substantial upside potential. The company delivers a robust return on equity and solid free cash flow, supporting its dividend yield and suggesting the payout is sustainable. Volume has been rising, which may signal renewed buying interest as investors eye the gap between current price and intrinsic value. However, high recent volatility and a sizeable max drawdown underscore the risk of further downside before any recovery materialises.
The sector’s defensive nature and the firm’s diversified retail and distribution footprint mitigate some of the macro‑economic headwinds facing South Africa, while a low beta reflects limited sensitivity to broader market swings. Given the attractive valuation, strong cash generation, and dividend appeal, the stock appears positioned for a medium‑ to long‑term rebound despite short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price below key moving averages
  • RSI in oversold territory
  • increasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • substantial DCF upside
  • PE ratio well under industry average
  • strong ROE and free cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • sustainable dividend yield
  • high return on equity
  • defensive healthcare retail exposure

Key Metrics & Analysis

Financial Health

Revenue Growth7.40%
Profit Margin6.72%
P/E Ratio16.7
ROE53.34%
ROA13.80%
Debt/Equity72.38
P/B Ratio9.0
Op. Cash FlowZAC5.3B
Free Cash FlowZAC3.8B
Industry P/E27.2

Technical Analysis

TrendBearish
RSI29.1
SupportZAC 23,222.00
ResistanceZAC 27,199.00
MA 20ZAC 24,786.35
MA 50ZAC 27,090.36
MA 200ZAC 32,573.63
MACDBearish
VolumeIncreasing
Fear & Greed Index92.75

Valuation

Fair ValueZAC 28,290.94
Target PriceZAC 35,887.50
Upside/Downside53.04%
GradeUndervalued
TypeBlend
Dividend Yield3.86%

Risk Assessment

Beta-0.05
Volatility34.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.